Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Calculate exactly how many units of SS-31 to draw on your syringe. Pre-filled with standard defaults.
Draw on your syringe
1,600
units
(16.000 mL)
100.0% of syringe capacity
Concentration
2,500
mcg/mL
Dose volume
16.000
mL
Doses per vial
0
doses
Cost per dose
---
enter price
Total mcg in vial = 5 mg x 1000 = 5,000 mcg
Concentration = 5,000 mcg / 2 mL = 2,500 mcg/mL
Dose volume = 40000 mcg / 2,500 mcg/mL = 16.0000 mL
Units to draw = 16.0000 mL x 100 units/mL = 1,600 units
Doses per vial = 5,000 mcg / 40000 mcg = 0.13 doses
Want the full Disclosed Trust Index?
Create a free account to unlock vendor trust scores, the COA scanner, the Forgery Map, and lot lookup across the corpus.
Create a free accountSS-31 (elamipretide) is a mitochondria-targeted tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) developed by Hazel Szeto (Cornell) and clinically advanced by Stealth BioTherapeutics. It concentrates in the inner mitochondrial membrane by binding cardiolipin. In September 2025, the FDA granted accelerated approval to elamipretide (brand name FORZINITY) as the first therapy for Barth syndrome — the first FDA-approved mitochondria-targeted drug. It remains investigational for other indications.
Common vial size
5
mg
Typical BAC water
2
mL
Dose range
40000–80000
mcg
Default dose
40000
mcg
Store refrigerated (2-8°C). Once reconstituted, use within 28 days.
Disclosed Labs